Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04683653

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

RT-PACE: Phase I/II Study of Adjuvant Whole Pelvic Hypofractionated Radiotherapy for Non-Metastatic Cervical and Endometrial Cancer

Status
Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will investigate if a shorter treatment course (known as "hypofractionation") for pelvic radiation is safe for women with endometrial cancer. Doctors leading the study will also determine the safest and most tolerable dose of shortened radiation (hypofractionation) used to treat women in this study. Because this study will shorten the radiation course typically used to treat endometrial cancer, each daily treatment given to women in this study will be slightly higher than normal to ensure that the total radiation dose they receive is still effective and similar to the radiation dose they would receive if they were not participating in this study (standard treatment).

Conditions

Interventions

TypeNameDescription
RADIATIONHypofractionated RadiationRadiation treatment in which the total dose of radiation is divided into large doses and treatments are given less often. Hypofractionated radiation therapy is given over a shorter period of time (fewer days or weeks) than standard radiation therapy.
OTHERClinical Follow-Up and AssessmentsAt each visit, the subject will be evaluated for any signs of their endometrial cancer or symptoms returning (clinical disease recurrence) and any negative side effects associated with their prior radiation treatment. Study participants will also be asked to fill out a survey regarding bowel/urinary habits and quality of life questionnaires (known as the "EPIC questionnaire") during these visits. The data collected during these clinical follow up visits will be used to determine how effective hypofractionated/shortened whole radiation therapy is for treating endometrial cancer.

Timeline

Start date
2021-01-15
Primary completion
2027-05-22
Completion
2027-05-22
First posted
2020-12-24
Last updated
2025-12-29

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04683653. Inclusion in this directory is not an endorsement.